No Cover Image

Journal article 1416 views

Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials

Jiten Vora, Torsten Christensen, Azhar Rana, Steve Bain Orcid Logo

Diabetes Therapy, Volume: 5, Issue: 2, Pages: 435 - 446

Swansea University Author: Steve Bain Orcid Logo

Full text not available from this repository: check for access using links below.

DOI (Published version): 10.1007/s13300-014-0076-9

Published in: Diabetes Therapy
Published: 2014
URI: https://cronfa.swan.ac.uk/Record/cronfa20199
first_indexed 2015-02-25T02:59:58Z
last_indexed 2018-02-09T04:56:27Z
id cronfa20199
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2016-03-12T11:18:55.2774699</datestamp><bib-version>v2</bib-version><id>20199</id><entry>2015-02-24</entry><title>Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2015-02-24</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes Therapy</journal><volume>5</volume><journalNumber>2</journalNumber><paginationStart>435</paginationStart><paginationEnd>446</paginationEnd><publisher/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2014</publishedYear><publishedDate>2014-12-31</publishedDate><doi>10.1007/s13300-014-0076-9</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2016-03-12T11:18:55.2774699</lastEdited><Created>2015-02-24T09:39:17.9438751</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Jiten</firstname><surname>Vora</surname><order>1</order></author><author><firstname>Torsten</firstname><surname>Christensen</surname><order>2</order></author><author><firstname>Azhar</firstname><surname>Rana</surname><order>3</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>4</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2016-03-12T11:18:55.2774699 v2 20199 2015-02-24 Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2015-02-24 MEDS Journal Article Diabetes Therapy 5 2 435 446 31 12 2014 2014-12-31 10.1007/s13300-014-0076-9 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2016-03-12T11:18:55.2774699 2015-02-24T09:39:17.9438751 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Jiten Vora 1 Torsten Christensen 2 Azhar Rana 3 Steve Bain 0000-0001-8519-4964 4
title Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
spellingShingle Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
Steve Bain
title_short Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
title_full Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
title_fullStr Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
title_full_unstemmed Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
title_sort Insulin Degludec Versus Insulin Glargine in Type 1 and Type 2 Diabetes Mellitus: A Meta-Analysis of Endpoints in Phase 3a Trials
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Jiten Vora
Torsten Christensen
Azhar Rana
Steve Bain
format Journal article
container_title Diabetes Therapy
container_volume 5
container_issue 2
container_start_page 435
publishDate 2014
institution Swansea University
doi_str_mv 10.1007/s13300-014-0076-9
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 0
active_str 0
published_date 2014-12-31T03:36:00Z
_version_ 1851362598006554624
score 11.089572

Similar Items